Thrombotic thrombocytopenic purpura: treatments, associated drugs and conditions

Summary:

Thrombotic thrombocytopenic purpura: a rare blood disorder characterized by clotting in small blood vessels of the body.

We study 6,447 people who have Thrombotic thrombocytopenic purpura. The information that eHealthMe analyzes includes:

- Medications that treat Thrombotic thrombocytopenic purpura and their effectiveness
- 447 drugs that are associated with Thrombotic thrombocytopenic purpura



Number of reports submitted per year:

Thrombotic thrombocytopenic purpura: 6,447 reports.

All the drugs that are associated with Thrombotic thrombocytopenic purpura:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.



Recent studies on eHealthMe: